Antiplatelet Versus Warfarin Therapy: Platelet, Neutrophil, and Thrombus Deposition for Intracoronary Stents in a Porcine Model
- 1 October 1997
- journal article
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 10 (5) , 349-356
- https://doi.org/10.1111/j.1540-8183.1997.tb00053.x
Abstract
Antiplatelet therapy may offer an advantage over warfarin in reducing adverse clinical events after intracoronary stem implantation. The mechanism of this effect has not been elucidated but platelet adhesion may play a predominant role in the process of subacute stent thrombosis. This study compared the effect on platelet, neutrophil, and thrombus deposition of three different anticoagulation regimens (aspirin/warfarin vs aspirin/ticlopidine vs aspirin alone) after intracoronary stenting in juvenile swine. Thirty stents were deployed in 15 juvenile farm swine randomized to one of 3 anticoagulation protocols: aspirin 325 mg/day; aspirin 325 mg/day and ticlopidine 500 mg/day; aspirin 325 mg/day and warfarin 0.1 mg/kg/day. Autologous platelets were labeled using 111Indium‐oxime and a slotted tube metal stent was deployed using a high pressure balloon. Platelet deposition in the stented segment was determined at 24 hours. Each segment was analyzed by light microscopy to document an injury score; mean and maximum thrombus deposition per strut were measured; and neutrophils were counted on each metal strut and in the vessel wall. Platelet deposition at 24 hours was significantly higher in the aspirin/warfarin group (3.69 ± 1.16 ± 108 plts/cm2) than in the aspirin/ticlopidine (1.74 ± 0.45 ± 108 plts/cm2, P = 0.0009) or aspirin (2.42 ± 2.13 ± 108 plts/cm2, P = 0.03) groups. There was no significant difference between the aspirin and aspirin/ticlopidine groups (P = 0.9). Mean thrombus area per strut was significantly greater in the aspirin/warfarin group (0.027 ± 0.006 mm2) compared to the aspirin/ticlopidine group (0.017 ± 0.002 mm2, P = 0.002). The majority of the thrombus (79%) but minority of neutrophils (24%) were found on the stent struts. In this coronary stent model, warfarin given with aspirin was associated with greater thrombogenicity and more platelet deposition than either aspirin/ticlopidine or aspirin alone.Keywords
This publication has 33 references indexed in Scilit:
- Stratification of the risk of thrombosis after intracoronary stenting for threatened or acute closure complicating coronary balloon angioplasty: A Cook registry studyAmerican Heart Journal, 1995
- Increase of neutrophil adhesion and vasoconstriction with platelet deposition after deep arterial injury by angioplastyAmerican Heart Journal, 1995
- Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stentingCatheterization and Cardiovascular Diagnosis, 1994
- Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stentsAmerican Heart Journal, 1993
- Effects of thrombocytopenia and shear rate on neutrophil and platelet deposition on endothelial and medial arterial surfaces.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Safety, success, and restenosis after elective coronary implantation of the Palmaz-Schatz stent in 100 patients at a single centerAmerican Heart Journal, 1993
- Effect of warfarin on arterial thrombogenesis: Problems of monitoringAmerican Journal of Hematology, 1993
- Thrombosis of a flexible coil coronary stent: Frequency, predictors and clinical outcomeJournal of the American College of Cardiology, 1993
- Modification of the Thrombogenicity of a Self-Expanding Vascular StentJournal of Investigative Surgery, 1991
- Quantification of platelet retention in aortocoronary femoral vein bypass graft in dogs treated with dipyridamole and aspirin.Circulation, 1984